We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIVB
701
DELISTED
SVB Financial Group
SIVB
$854K 0.01%
3,709
-16
-0.4% -$3.97K
GNRC icon
702
Generac Holdings
GNRC
$11.5B
$853K 0.01%
8,479
-946
-10% -$107K
ANNX icon
703
Annexon
ANNX
$814M
$851K 0.01%
164,558
-992
-0.6% -$5.45K
BN icon
704
Brookfield
BN
$104B
$848K 0.01%
40,455
-10,831
-21% -$243K
NVRO
705
DELISTED
NEVRO CORP.
NVRO
$843K 0.01%
21,278
-224
-1% -$9.31K
RDNT icon
706
RadNet
RDNT
$4.97B
$842K 0.01%
44,692
-3,172
-7% -$59.3K
TNDM icon
707
Tandem Diabetes Care
TNDM
$1.22B
$835K 0.01%
18,587
-23,988
-56% -$1.09M
LNTH icon
708
Lantheus
LNTH
$6.68B
$835K 0.01%
16,386
+4,109
+33% +$254K
COWN
709
DELISTED
Cowen Inc. Class A Common Stock
COWN
$833K 0.01%
21,578
– –
SUI icon
710
Sun Communities
SUI
$15.3B
$833K 0.01%
5,827
– –
CERS icon
711
Cerus
CERS
$585M
$829K 0.01%
227,107
-18,684
-8% -$70.4K
KNTE
712
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$825K 0.01%
135,298
+68,941
+104% +$561K
ACH
713
Accendra Health
ACH
$249M
$825K 0.01%
42,252
+2,652
+7% +$51.7K
OPK icon
714
Opko Health
OPK
$1.23B
$818K 0.01%
654,601
+202,253
+45% +$319K
NARI
715
DELISTED
Inari Medical, Inc. Common Stock
NARI
$814K 0.01%
12,809
-1,625
-11% -$118K
CSL icon
716
Carlisle Companies
CSL
$14.1B
$804K 0.01%
+3,414
New +$878K
FMC icon
717
FMC
FMC
$1.37B
$789K 0.01%
6,323
-2,635
-29% -$323K
AHCO icon
718
AdaptHealth
AHCO
$1.53B
$787K 0.01%
40,931
-13,876
-25% -$293K
LSXMK
719
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$784K 0.01%
25,879
-12,297
-32% -$393K
TU icon
720
Telus
TU
$16.7B
$771K 0.01%
39,956
-5,751
-13% -$119K
AMN icon
721
AMN Healthcare
AMN
$1.35B
$770K 0.01%
7,492
-2,045
-21% -$236K
TVRD
722
Tvardi Therapeutics
TVRD
$22.9M
$769K 0.01%
1,990
-525
-21% -$199K
TAP icon
723
Molson Coors Class B
TAP
$7.97B
$747K 0.01%
14,509
– –
U icon
724
Unity
U
$13.9B
$747K 0.01%
26,124
-4,149
-14% -$130K
ZM icon
725
Zoom
ZM
$26.8B
$744K 0.01%
+10,981
New +$834K
27 28
29
30 31

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.